Carregant...
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer
Primary platinum-based chemoresistance occurs in ~30% of patients with serous ovarian cancer. Chemoresistance is the main cause of disease recurrence, and accurate predictors to identify these patients with chemoresistance are required. Alternative splicing (AS) is a post-transcriptional modificatio...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7285883/ https://ncbi.nlm.nih.gov/pubmed/32565967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11562 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|